Ventricular Arrhythmias in Ischemic Cardiomyopathy—New Avenues for Mechanism-Guided Treatment
Ischemic heart disease is the most common cause of lethal ventricular arrhythmias and sudden cardiac death (SCD). In patients who are at high risk after myocardial infarction, implantable cardioverter defibrillators are the most effective treatment to reduce incidence of SCD and ablation therapy can...
Main Authors: | Matthew Amoni, Eef Dries, Sebastian Ingelaere, Dylan Vermoortele, H. Llewelyn Roderick, Piet Claus, Rik Willems, Karin R. Sipido |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/10/2629 |
Similar Items
-
Temporal Changes in Beat‐to‐Beat Variability of Repolarization Predict Imminent Nonsustained Ventricular Tachycardia in Patients With Ischemic and Nonischemic Dilated Cardiomyopathy
by: Matthew Amoni, et al.
Published: (2022-07-01) -
Arritmias ventriculares e hipertrofia ventricular esquerda na cardiomiopatia hipertrófica Ventricular arrhythmias and left ventricular hypertrophy in hypertrophic cardiomyopathy
by: Beatriz Piva e Mattos, et al.
Published: (2013-05-01) -
Beneficial Effect of Renal Denervation on Ventricular Premature Complex Induced Cardiomyopathy
by: Shinya Yamada, et al.
Published: (2017-03-01) -
Mitochondrial Dysfunction in Arrhythmia and Cardiac Hypertrophy
by: Xiaomei Wang, et al.
Published: (2023-12-01) -
Benefits of SGLT2 inhibitors in arrhythmias
by: Jinghan Gao, et al.
Published: (2022-10-01)